These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4050782)

  • 1. Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis.
    Hou SH; Grossman S; Molitch ME
    Am J Kidney Dis; 1985 Oct; 6(4):245-9. PubMed ID: 4050782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels and peritoneal loss of prolactin in CAPD patients.
    Kagan A; Gertler A; Ulman M; Bar-Khayim Y
    Adv Perit Dial; 1991; 7():247-52. PubMed ID: 1680437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis.
    Lo JC; Beck GJ; Kaysen GA; Chan CT; Kliger AS; Rocco MV; Chertow GM;
    Hemodial Int; 2017 Apr; 21(2):190-196. PubMed ID: 27774730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior pituitary dysfunction in patients with chronic renal failure treated by hemodialysis or continuous ambulatory peritoneal dialysis.
    Rodger RS; Dewar JH; Turner SJ; Watson MJ; Ward MK
    Nephron; 1986; 43(3):169-72. PubMed ID: 3523268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cessation of galactorrhea in a chronic kidney disease patient with non-tumoral hyperprolactinemia after renal transplantation.
    Pratap B; Sundaram V; Abraham G; Matthew M; Bhaskar S
    J Assoc Physicians India; 2008 Jan; 56():54-5. PubMed ID: 18472504
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperprolactinemia associated with chronic renal failure in the rat.
    Torres-Noriega J; Frohman LA
    Horm Metab Res; 1986 Apr; 18(4):241-3. PubMed ID: 3710420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia as a marker of neurotransmitter imbalance in uremic population.
    Biasioli S; D'Andrea G; Micieli G; Feriani M; Borin D; Chiaramonte S; Cananzi A; La Greca G
    Int J Artif Organs; 1987 Jul; 10(4):245-57. PubMed ID: 2889675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does hyperprolactinaemia predispose to aluminium toxicity in chronic renal failure?
    Corbett T; de Takats D; Tattersall JE; Greenwood RN; Farrington K
    Nephrol Dial Transplant; 1994; 9(3):320-2. PubMed ID: 8052442
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteration of pituitary-thyroid function in patients with chronic renal failure treated by haemodialysis or continuous ambulatory peritoneal dialysis.
    Ross RJ; Goodwin FJ; Houghton BJ; Boucher BJ
    Ann Clin Biochem; 1985 Mar; 22 ( Pt 2)():156-60. PubMed ID: 3923894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis.
    Shusterman NH; Wasserstein AG; Morrison G; Audet P; Fallon MD; Kaplan F
    Am J Med; 1987 Jun; 82(6):1148-56. PubMed ID: 3605132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total body zinc depletion and its relationship to the development of hyperprolactinemia in chronic renal insufficiency.
    Caticha O; Norato DY; Tambascia MA; Santana A; Stephanou A; Sarlis NJ
    J Endocrinol Invest; 1996; 19(7):441-8. PubMed ID: 8884538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of long term dialysis therapy on blood prolactin patients with chronic renal failure].
    Pachelski J; Kokot F; Grzeszczak W
    Pol Tyg Lek; 1989 Feb; 44(9):214-6. PubMed ID: 2813182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperprolactinemia in chronic kidney failure patients].
    Milanov S; Belovezhdov N; Gruev I; Milkov V; Neshev G
    Vutr Boles; 1983; 22(2):111-4. PubMed ID: 6659479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy.
    Yavuz D; Topçu G; Ozener C; Akalin S; Sirikçi O
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):520-4. PubMed ID: 16268803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diurnal rhythm and the effect of hemodialysis therapy on blood prolactin levels in patients with chronic renal insufficiency].
    Bolićević M; Strahinjić S; Ivić M; Miljković P; Stefanović V
    Srp Arh Celok Lek; 1990; 118(9-10):347-52. PubMed ID: 2102550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin.
    Schaefer RM; Kokot F; Kuerner B; Zech M; Heidland A
    Int J Artif Organs; 1989 Jul; 12(7):445-9. PubMed ID: 2767790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prolactin and macroprolactin levels in diabetic nephropathy.
    Sari F; Sari R; Ozdem S; Sarikaya M; Cetinkaya R
    Clin Nephrol; 2012 Jul; 78(1):33-9. PubMed ID: 22732335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth hormone / prolactin].
    Nagasaki T; Inaba M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():173-7. PubMed ID: 15250290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.